Cargando…
AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
BACKGROUND: Adiponectin (ApN) is a hormone known to exhibit insulin‐sensitizing, fat‐burning, and anti‐inflammatory properties in several tissues, including the skeletal muscle. Duchenne muscular dystrophy (DMD) is a devastating disease characterized by dystrophin deficiency with subsequent chronic...
Autores principales: | Abou‐Samra, Michel, Selvais, Camille M., Boursereau, Raphael, Lecompte, Sophie, Noel, Laurence, Brichard, Sonia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113498/ https://www.ncbi.nlm.nih.gov/pubmed/31965757 http://dx.doi.org/10.1002/jcsm.12531 |
Ejemplares similares
-
Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
por: Boursereau, Raphaël, et al.
Publicado: (2018) -
AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers
por: Selvais, Camille M., et al.
Publicado: (2022) -
Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin
por: Lecompte, S., et al.
Publicado: (2017) -
AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017) -
Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy
por: Dubuisson, Nicolas, et al.
Publicado: (2022)